{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:20:11Z","timestamp":1792801211507,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T00:00:00Z","timestamp":1168992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2007,2,28]]},"DOI":"10.1007\/s11011-006-9039-9","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T01:16:26Z","timestamp":1168996586000},"page":"105-109","source":"Crossref","is-referenced-by-count":61,"title":["Valproic Acid Aggravates Epilepsy due to MELAS in a Patient with an A3243G Mutation of Mitochondrial DNA"],"prefix":"10.1007","volume":"22","author":[{"given":"Chih-Ming","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peterus","family":"Thajeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,17]]},"reference":[{"key":"9039_CR1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1528-1157.1992.tb02356.x","volume":"33","author":"U Altrup","year":"1992","unstructured":"Altrup U, Gerlach G, Reith H, Said MN, Speckmann EJ (1992) Effects of valproate in model nervous system (buccal ganglia of Helix pomatia): I. Antiepileptic actions. Epilepsia 33:743\u2013752","journal-title":"Epilepsia"},{"key":"9039_CR2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1528-1157.1992.tb02357.x","volume":"33","author":"U Altrup","year":"1992","unstructured":"Altrup U, Reith H, Speckmann EJ (1992) Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia): II. Epileptogenic actions. Epilepsia 33:753\u2013759","journal-title":"Epilepsia"},{"key":"9039_CR3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0242-6498(05)80131-2","volume":"25","author":"K Aure","year":"2005","unstructured":"Aure K, Jardel C, Lombes A (2005) Mitochondrial diseases: Molecular mechanisms, clinical presentations and diagnosis investigations. Ann Pathol 25:270\u2013281","journal-title":"Ann Pathol"},{"key":"9039_CR4","first-page":"133","volume":"153","author":"B Chabrol","year":"1994","unstructured":"Chabrol B, Mancini J, Chretien D, Rustin P, Munnich A, Pinsard N (1994) Valproate-induced hepatic failure in a case of cytochrome c oxidase deficiency. Eur J Pediatr 153:133\u2013135","journal-title":"Eur J Pediatr"},{"key":"9039_CR5","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/brain\/120.10.1713","volume":"120","author":"PF Chinnery","year":"1997","unstructured":"Chinnery PF, Howell N, Lightowlers RN, Tumball DM (1997) Molecular pathology of MELAS and MERRF: The relationship between mutation load and clinical phenotypes. Brain 120:1713\u20131721","journal-title":"Brain"},{"key":"9039_CR6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/07853890510007368","volume":"37","author":"S Dimauro","year":"2005","unstructured":"Dimauro S, Davidzon G (2005) Mitochondrial DNA and disease. Ann Med 37:222\u2013232","journal-title":"Ann Med"},{"key":"9039_CR7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1034\/j.1600-0676.2000.020004346.x","volume":"20","author":"S Krahenbuhl","year":"2000","unstructured":"Krahenbuhl S, Brandner S, Kleinle S, Liechti S, Straumann D (2000) Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure. Liver 20:346\u2013348","journal-title":"Liver"},{"key":"9039_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00019052-200204000-00009","volume":"15","author":"WS Kunz","year":"2002","unstructured":"Kunz WS (2002) The role of mitochondria in epileptogenesis. Curr Opin Neurol 15:179\u2013184","journal-title":"Curr Opin Neurol"},{"key":"9039_CR9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s004310050663","volume":"156","author":"CW Lam","year":"1997","unstructured":"Lam CW, Lau CH, Williams JC, Chan YW, Wong LJ (1997) Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy. Eur J Pediatr 156:562\u2013564","journal-title":"Eur J Pediatr"},{"key":"9039_CR10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1600-0404.1994.tb02737.x","volume":"90","author":"CW Liou","year":"1994","unstructured":"Liou CW, Huang CC, Chee EC, Jong YJ, Tsai JL, Pang CY, Lee HC, Wei YH (1994) MELAS Syndrome: Correlation between clinical features and molecular genetic analysis. Acta Neurol Scand 90:354\u2013359","journal-title":"Acta Neurol Scand"},{"key":"9039_CR11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1478-3231.1999.tb00063.x","volume":"19","author":"AA Morris","year":"1999","unstructured":"Morris AA (1999) Mitochondrial respiratory chain disorders and the liver. Liver 19:357\u2013368","journal-title":"Liver"},{"key":"9039_CR12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.410160409","volume":"16","author":"SG Pavlakis","year":"1984","unstructured":"Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: A distinctive clinical syndrome. Ann Neurol 16:481\u2013488","journal-title":"Ann Neurol"},{"key":"9039_CR13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/0006-2952(92)90590-F","volume":"43","author":"S Ponchaut","year":"1992","unstructured":"Ponchaut S, Van Hoof F, Veitch K (1992) Cytochrome aa3 depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration. Biochem Pharmacol 43:644\u2013647","journal-title":"Biochem Pharmacol"},{"key":"9039_CR14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01972980","volume":"154","author":"S Ponchaut","year":"1995","unstructured":"Ponchaut S, Van Hoof F, Veitch K (1995) Valproate and cytochrome c oxidase deficiency. Eur J Pediatr 154:79","journal-title":"Eur J Pediatr"},{"key":"9039_CR15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00023210-200620060-00002","volume":"20","author":"F Scaglia","year":"2006","unstructured":"Scaglia F, Northrop JP (2006) The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: A review of treatment options. CNS Drugs 20:443\u2013464","journal-title":"CNS Drugs"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-006-9039-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-006-9039-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-006-9039-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:21:44Z","timestamp":1559355704000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-006-9039-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,17]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2,28]]}},"alternative-id":["9039"],"URL":"https:\/\/doi.org\/10.1007\/s11011-006-9039-9","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,17]]}}}